Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines
Sale

Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines

Elsevier Science Publishing Co Inc
SKU:
9780128042175
|
UPC:
9780128042175
$137.65 $122.40
(No reviews yet)
Condition:
New
Current Stock:
Adding to cart… The item has been added
Description



  • | By (Author): Tom Brody (Consultant for Second Genome, Inc. (Crohn's disease), Rigel Pharmaceuticals (platelet disorder), PrimeGen Biotech (stem cell therapy), Regeneron Pharmaceuticals (broadly neutralizing antibodies for HIV), and Biogen IDEC (multiple sclerosis)) (Author)
  • | Publisher: Elsevier Science Publishing Co Inc
  • | Publication Date: Mar 14, 2016
  • | Country of Publication: United States
  • | Number of Pages: 896 pages
  • | Language: NULL
  • | Binding: Hardback
  • | ISBN-10: 0128042176
  • | ISBN-13: 9780128042175
Additional Information
By (Author):
Tom Brody (Consultant for Second Genome, Inc. (Crohn's disease), Rigel Pharmaceuticals (platelet disorder), PrimeGen Biotech (stem cell therapy), Regeneron Pharmaceuticals (broadly neutralizing antibodies for HIV), and Biogen IDEC (multiple sclerosis
Publisher:
Elsevier Science Publishing Co Inc
Publication Date:
Mar 14, 2016
Country of Publication:
United States
Language:
NULL
Number of pages:
896 pages
Binding:
Hardback
ISBN-10:
0128042176
ISBN-13:
9780128042175
Related Products